Relmada Therapeutics Return On Tangible Equity 2013-2024 | RLMD

Relmada Therapeutics return on tangible equity from 2013 to 2024. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.

Relmada Therapeutics Return On Tangible Equity 2013-2024 | RLMD

Relmada Therapeutics return on tangible equity from 2013 to 2024. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.